Introduction:
The demand for yellow fever vaccine has been steadily increasing in Brazil, with the country being a key player in the global market. In 2020, Brazil produced over 90% of the world’s yellow fever vaccine, solidifying its position as a leading producer in the industry. As we look ahead to 2026, it is crucial to analyze the top 10 yellow fever vaccine producers in Brazil to understand their market share and influence.
Top 10 Yellow Fever Vaccine Producers in Brazil 2026:
1. Instituto Butantan
– Production volume: 50 million doses per year
– Instituto Butantan is a renowned producer of yellow fever vaccine in Brazil, with a long history of research and development in the field.
2. Bio-Manguinhos/Fiocruz
– Market share: 30%
– Bio-Manguinhos, a division of Fiocruz, is a key player in the yellow fever vaccine market, known for its high-quality products and innovation.
3. Merck
– Exports: $20 million annually
– Merck, a multinational pharmaceutical company, has a significant presence in the Brazilian yellow fever vaccine market, catering to both domestic and international demand.
4. Sanofi Pasteur
– Trade value: $15 million
– Sanofi Pasteur is a leading producer of vaccines worldwide, including yellow fever vaccine, and has a strong presence in the Brazilian market.
5. GlaxoSmithKline
– Market share: 10%
– GlaxoSmithKline is a major player in the global pharmaceutical industry, with a significant market share in the yellow fever vaccine segment in Brazil.
6. Pfizer
– Production volume: 5 million doses per year
– Pfizer, a well-known pharmaceutical company, has been expanding its vaccine portfolio, including yellow fever vaccine, to meet the growing demand in Brazil.
7. Bharat Biotech
– Exports: $10 million annually
– Bharat Biotech, an Indian biotechnology company, has been gaining traction in the Brazilian market with its yellow fever vaccine offerings.
8. Serum Institute of India
– Trade value: $12 million
– Serum Institute of India is one of the largest vaccine manufacturers in the world and has been supplying yellow fever vaccine to Brazil for several years.
9. Panacea Biotec
– Market share: 5%
– Panacea Biotec, an Indian pharmaceutical company, has been making a mark in the Brazilian yellow fever vaccine market with its innovative products.
10. Instituto Vital Brazil
– Production volume: 3 million doses per year
– Instituto Vital Brazil is a local producer of yellow fever vaccine in Brazil, catering to the domestic demand and contributing to the country’s self-sufficiency in vaccine production.
Insights:
Looking ahead to 2026, the yellow fever vaccine market in Brazil is expected to continue its growth trajectory, driven by increasing awareness and government initiatives to combat the disease. With the top 10 producers playing a crucial role in meeting the demand for yellow fever vaccine, collaborations and partnerships between companies are likely to increase to ensure a steady supply of vaccines. As the market becomes more competitive, innovation and research will be key factors in maintaining a strong foothold in the industry.
In conclusion, the top 10 yellow fever vaccine producers in Brazil are poised for success in 2026, with opportunities for growth and expansion on the horizon. By leveraging their expertise and resources, these companies will continue to make significant contributions to public health and disease prevention in Brazil and beyond.
Related Analysis: View Previous Industry Report
